Your browser doesn't support javascript.
loading
Corrigendum to "Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension" [J Hepatol 62 (2015) 325-331].
Mookerjee, Rajeshwar P; Mehta, Gautam; Balasubramaniyan, Vairappan; Mohamed, Fatma El Zahraa; Davies, Nathan; Sharma, Vikram; Iwakiri, Yasuko; Jalan, Rajiv.
Afiliação
  • Mookerjee RP; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK. Electronic address: r.mookerjee@ucl.ac.uk.
  • Mehta G; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
  • Balasubramaniyan V; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
  • Mohamed FEZ; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK; Pathology Department, Faculty of Medicine, Minia University, Egypt.
  • Davies N; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
  • Sharma V; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
  • Iwakiri Y; Sections of Digestive Diseases, Department of Medicine, Yale University School of Medicine, New Haven, CT, USA.
  • Jalan R; Liver Failure Group, Institute for Liver and Digestive Health, University College London, UK.
J Hepatol ; 67(5): 1124, 2017 11.
Article em En | MEDLINE | ID: mdl-28893453
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article